(Q54580077)

English

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Timothy J McDonald

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Andrew Tym Hattersley

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

K Y Thong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A D Blann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Ramtoola

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Duncan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Carr

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Adamson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

R Khurana

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S J Hunter

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Ali

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Au

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

R E J Ryder

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

6 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

403-411

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24246138%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Recent advances in incretin-based therapies

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Exenatide efficacy and safety: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Exenatide once-weekly clinical development: safety and efficacy across a range of background therapies

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Incretin effects on β-cell function, replication, and mass: the human perspective

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

The role of adjunctive exenatide therapy in pediatric type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Quantitation of Human Pancreatic Beta-cell Function by Immunoassay of C-Peptide in Urine

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FDME.12367

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54580077&oldid=1126563126"